# Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation

> **NCT03751631** · PHASE3 · COMPLETED · sponsor: **Eyenovia Inc.** · enrollment: 70 (actual)

## Conditions studied

- Mydriasis

## Interventions

- **DRUG:** Tropicamide 1%-Phenylephrine 2.5% ophthalmic solution (TR/PE)
- **DRUG:** Tropicamide 1% ophthalmic solution (TR)
- **DRUG:** Phenylephrine 2.5% ophthalmic solution (PE)

## Key facts

- **NCT ID:** NCT03751631
- **Lead sponsor:** Eyenovia Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-15
- **Primary completion:** 2019-01-11
- **Final completion:** 2019-01-11
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2022-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03751631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03751631, "Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03751631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*